Davy James, Associate Editor

Primary androgen-deprivation therapy appears not to be an effective treatment for men with clinically localized prostate cancer.

In an interview with Specialty Pharmacy Times, James E. Smeeding, executive director of the National Association of Specialty Pharmacy, discusses the organization's future and issues in the specialty marketplace.

Study finds aspirin improves survival outcomes only for patients with HLA class I antigen expression.

Celgene's Abraxane is expected to drive expansion of pancreatic cancer therapeutics market.

Study suggests that standard dose of GnRH antagonist clears out of obese women's systems more quickly than in normal-weight women.

Express Scripts Senior Clinical Consultant Aimee Tharaldson, PharmD, discusses specialty pharmacy treatment options for 2014 and beyond.

Efficacy of standard dose can be suboptimal in patients with hepatitis C, study shows.

National Association of Specialty Pharmacy brings together hundreds of stakeholders to discuss the rapidly changing special medication landscape.

Complexity of specialty drugs leads most health plans to create specific rules for coverage, cost share, and benefit management, survey indicates.

Patients with co-infection are 80% more likely to have serious liver disease than patients with hepatitis C alone, study finds.

Incidence rates decreased 3% per year last decade thanks in part to timely screening tests, report says.

Hy-Vee's chief health officer says growth of specialty drug market spurred grocery chain to purchase Amber Pharmacy.

Study indicates inflammatory bowel disease treatment needs careful consideration before prescribing.

Study finds significant racial and geographic disparity in prevalence of monoclonal gammopathy of undetermined significance.

An increase in the number of available anti-cancer drugs will also help lead to more people surviving the disease than ever before.

Integrated clinical and specialty pharmacy practice model includes an interdisciplinary team of physicians, nurses, and pharmacists.

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.

The Midwestern grocery chain has reached agreement to purchase specialty pharmacy solutions provider Amber Pharmacy.

Deaths from chronic hepatitis C virus infection in the United States are grossly underreported, the results of a new study indicate.

Double-digit annual spending increases for specialty drugs are forecast through 2015, reports America's Health Insurance Plans.

A child born infected with HIV in California began treatment hours after birth, and is clear of virus 9 months later.